Mesoblast (MESO) Revenue (2016 - 2023)

Mesoblast's Revenue history runs 8 years deep, the most recent figure standing at -$5.4 million for Q2 2023.

• In Q2 2023, Revenue fell 341.1% year-over-year to -$5.4 million; the TTM figure through Mar 2023 stood at $7.6 million (down 13.9% YoY), while the FY2025 annual figure was $17.2 million, changed N/A from the prior year.
• Revenue came in at -$5.4 million for Q2 2023 at Mesoblast, down from $1.9 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $26.2 million in Q2 2020 to a low of -$5.4 million in Q2 2023.
• A 5-year average of $2.9 million and a median of $2.0 million in 2019 frame the typical range for Revenue.
• Across the five-year window, Revenue soared 1233.71% in 2020 and sank 341.1% in 2023, its largest moves.
• Mesoblast's Revenue stood at $2.0 million in 2019, then advanced by 13.81% to $2.2 million in 2020, then advanced by 6.29% to $2.4 million in 2021, then retreated by 16.88% to $2.0 million in 2022, then plunged by 370.81% to -$5.4 million in 2023.
• According to Business Quant data, Revenue over the past three periods registered -$5.4 million, $1.9 million, and $2.0 million for Q2 2023, Q1 2023, and Q4 2022 respectively.

Peer Comparison